Biogen Indicates EU Won’t Approve Alzheimer’s Drug A report in the New York Situations notes Biogen could not be expecting drug reviewers in the European Union to approve its Alzheimer’s drug Aduhelm — by now authorized, controversially, in the U.S. Meanwhile Aetna sues covid testing companies, and more. The New […]